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Abstract: The summary of product characteristics from the European Medicines Agency is a reference
document on medicines in the EU. It contains textual information for clinical experts on how to safely
use medicines, including adverse drug reactions. Using natural language processing (NLP) techniques
to automatically extract adverse drug reactions from such unstructured textual information helps clinical
experts to effectively and efficiently use them in daily practices. Such techniques have been developed
for Structured Product Labels from the Food and Drug Administration (FDA), but there is no research
focusing on extracting from the Summary of Product Characteristics. In this work, we built a natural
language processing pipeline that automatically scrapes the summary of product characteristics online
and then extracts adverse drug reactions from them. Besides, we have made the method and its output
publicly available so that it can be reused and further evaluated in clinical practices. In total, we
extracted 32,797 common adverse drug reactions for 647 common medicines scraped from the Electronic
Medicines Compendium. A manual review of 37 commonly used medicines has indicated a good
performance, with a recall and precision of 0.99 and 0.934, respectively.
Keywords: information extraction; natural language processing; adverse drug reactions; summary
of product characteristics
1. Introduction
Drug product labels are regulatory documents required as part of the marketing
authorization of each medicine. They provide up-to-date and comprehensive information
about the risks, benefits, and pharmacological properties of marketed medicines. As such,
extracting the clinical knowledge stored in product labels and making it available in the
form of computationally accessible knowledge bases would benefit several applications in
the area of drug safety surveillance and assessment. For example, during post-marketing
safety assessments, it is crucial to determine whether an investigated adverse drug reaction
(ADR) is already labeled [1,2].
There are two main versions of drug product labels around the world: Structured
Product Labels (SPL) introduced by the Food and Drug Administration (FDA) in the US,
and the Summary of Product Characteristics (SmPC) supervised by the European Medicines
Agency (EMA) in the EU [3]. Both product labels provide information in sections, and the
content of each section is in free narrative texts. This study focuses on the undesirable side
effect section of product labels which describes adverse drug reactions (ADRs).
To date, there are no structured machine-readable ADRs. Therefore, extracting
ADRs from unstructured product labels becomes an interesting research topic. There are
many studies focusing on transforming unstructured ADRs data into structured machine-
readable data [4–8]. However, the majority of current studies focus on the US version
of product labels. For example, systems such as SPLICER and SPL-X were developed to
extract ADR terms from particular sections using various natural language processing
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(NLP) techniques, including named entity recognition, rule-based parsing, and NegEx [4].
Fung et al. proposed to use open-source NLP tools to extract drug indication information
from SPL [5]. Wu et al. managed to fetch ADR terms using Oracle Text search from 1164
single-ingredient medicines [6]. A variety of NLP techniques were designed to extract
ADRs from SPL in the 2017 Text Analysis Conference track [2].
However, the FDA SPL is the main data source used in such studies. Until now, the
SmPC, as the European equivalent to SPL, has barely been investigated and no method has
been developed solely for extracting ADRs from the SmPC. This study contributes to the
field as a starting point.
In this study, the main research question we are addressing is how to utilize NLP
techniques to automatically extract ADRs from standardized European product labels,
namely SmPC. To answer the question, we first develop an NLP pipeline to extract adverse
drug reactions from SmPC. A knowledge base is created from the extracted terms. The main
characteristics of the NLP pipeline and the knowledge base are summarized as follows: (a)
open-source and reproducible; (b) customizable for related ad hoc tasks; (c) knowledge
base applicable for clinical studies.
The paper is structured as follows. Section 2 illustrates a number of methods and
materials used in our study. Then the results are presented in Section 3. Discussions in
Section 4 summarize the main findings of this research and some limitations. Section 5
concludes the study.
2. Materials and Methods
In this section, we describe the SmPC data source, elaborate on the various NLP
techniques that are applied to extract ADRs from SmPC, and briefly explain the evaluation
setup for validating our automatic ADR extraction approach. A conceptual overview of the
ADR extraction pipeline is illustrated in Figure 1. The first step is to scrape the side effects
data from the Electronic Medicines Compendium (EMC). Then the ADRs are extracted
accordingly. Finally, the performance of our NLP method is evaluated by both NLP and
clinical experts.
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2.1. Dataset
All SmPCs were scraped from the EMC which provides the most recent and openly
accessible regulated and approved information about medicines licensed in the UK [9]. The
EMC was selected as our data source for two main reasons: (1) all information is in English;
(2) it has more than 14,000 documents, all of which have been checked and approved by
the European government agencies. Figure 2 shows an example of the side effects section
of SmPC.
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2.2. Scraping the Side Effects Section of SmPC
Since this study focuses on commonly used medications, we only scrape the SmPCs of
a limited number of medicines in the EMC. As shown in Figure 1, the process of scraping
side effects data starts with identifying active substances. Then, for each active substance,
only one medication in tablet form is included in the final list which contains 647 medicines,
because the tablet form is the most common medicatio route. When there is no medicine
in tablet form for a given active substance, none is selected. At last, section 4.8 Undesirable
effects of the SmPC i obtained for all 647 medic tions in the final list. The 4.8 section
con ists of ADR inf rmation in both plain tex and structured tables, w scrap d th
av ilable information HTML format so that the data structure is kept. All data is s ored
as JSON file, which is used in the later steps.
2.3. xtraction
2.3.1. SmPC Processing
In the second phase of our NLP pipeline is ADR extraction. It starts with processing
the above-mentioned ADR relevant HTML excerpts. As we described before, the section
4.8 in the SmPC contains ADR information in diverse formats: plain text, structured text,
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and tables. Tables used in describing ADR information also come with different structural
styles. Therefore, we classify the 4.8 section into separate categories in terms of its content
structure. Figure 3 elaborates on the process of categorization. Each category has its own
ADR extraction technique.
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First, e i e tify a list f tr ct ral f t res i t r ts, i ,
co nts of ‘<table>’, the counts and positions of some MedDRA terms [10], such as the
frequency and SOC (System Organ Cla ses) [11]. Table 1 shows some spe ific examples
of such words. Secondly, the features are e gin ered from the scraped HTML files. Based
on the features, we obtain three main stru tural categories: structured text, free ext,
and tabular.
• ree-te t: s re e l i e in free-text, as shown in Figure 4a. ADRs are hidden i
sentences, which t us requires named entity recognition (NER) to extract them.
• Structured text: Rs are described in a structured text, as sho n in Figure 4b. It
depicts a list of Rs and their frequencies in an organized for at.
• Tabular: ADRs are presented in a very structured way, namely a table. Figure 4c shows
an example of such tables. These tables are further split into two groups: tabular
horizontal and tabular vertical.
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Table 1. Examples of ADR-specific terminologies.
Term Type Description Examples








The highest level of groupings in
MedDRA. There are 27 groups
which are defined by etiology [9].
Immune system disorders





Skin and subcutaneous tissue disorders
General disorders and administration site
conditions
Investigations







The highest level of group-
ings in MedDRA. There are 
27 groups which are defined 
by etiology [9]. 
Immune system disorders 
Metabolism and nutrition disorders 




Skin and subcu aneous tissue disorders 




Figure 4. Example fragments of the three main structural categories: (a) free text, (b) structured text, and (c) tabular text. 
2.3.2. ADR Extraction 
In the previous section, we identify three main structural categories that require dif-
ferent ADR extraction techniques, respectively. An overview of the extraction pipeline for 
each category is illustrated in Figure 5. 
Figure 4. Example fragments of the three main structural categories: (a) free text, (b) structured text, and (c) tabular text.
2.3.2. ADR Extraction
In the previous section, we identify three main structural categories that require
different ADR extraction techniques, respectively. An overview of the extraction pipeline
for each category is illustrated in Figure 5.
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Figure 5. An Overview of the ADR Extraction Pipeline.
To uncover the hidden ADRs in the free-text, entity extraction techniques are applied.
Specifically, we simplify the extraction process by using the IBM Watson Natural Language
Understanding API that offers sophisticated NLP techniques in extracting meta-data from
content such as concepts, entities, keywords, and others. Benchmarking studies have
shown that IBM Watson Natural Language Understanding API is a simple and useful NLP
tool in solving various clinical NLP problems [12,13]. A demonstration of how the API
works is available [14]. Since the number of ADR terms is relatively limited, we can use
the API for free. It offers a lite account which can process 30, 000 items per month free
of charge [15]. Frequencies of the extracted ADRs are assigned as unknown due to their
absence in the free texts.
For the structured text, we extract ADR terms and their corresponding frequencies
with syntax parsing. The syntactic structure of a structured HTML text is depicted by the
occurrences and positions of SOC (System Organ Class) and frequency terms. With the
identified positions of SOC and frequency terms, we can obtain the HTML elements that
contain only ADR terms. In most cases, ADRs terms in an HTML element are separated
by a comma. Thus, by splitting the string by comma, we extract several ADRs for a given
SOC and frequency. An example of such ADR extraction is illustrated in Figure 6. The left
is the structured text in HTML and the right side shows the extracted ADRs in JSON.
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The tabular text refers to HTML tables that describe ADRs of a given medicine in a
two-dimensional grid format. The first step of information extraction for HTML tables is to
detect the structure. As mentioned above, we identify two types of structures: vertical and
horizontal. Similar to structured text, ADR extraction starts with getting the occurrences
and positions of SOC and frequency terms. Then, with the position indexes of SOC and
Appl. Sci. 2021, 11, 2663 7 of 11
frequency terms, HTML table cells that contain ADR terms are fetched and processed.
ADR terms in an HTML table cell are usually separated by a comma. An example is given
in Figure 7.
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2.4. Evaluation
An expert manual review is performed in the evaluation of ADRs extracted from
the SmPCs in this study. To alleviate the burden of manual reviewing for our clinical
experts, we only sample a small subset of common medicines. Moreover, an NLP expert is
also involved in the manual review. The NLP expert specializes in processing the clinical
text and has a sufficient clinical knowledge to properly review the extracted ADRS. In
total, 37 medications were selected by the clinical expert for manual review. The clinical
expert provided a list of top 50 commonly used medicines in Dutch primary care, and
37 of 50 were available in our scrapped drug list. At the beginning of the evaluation,
both clinical and NLP experts are requested to review five identical medicines to align the
manual reviews of different experts. Following that, due to time constraints, the clinical
expert is asked to review five more medicines, whereas the NLP expert continues to review
32 more medicines.
For each medicine, all extracted ADRs are examined and labeled as ‘correct’, ‘near’,
or ‘inc rrect’. Furthermore, the number of missing ADRs is counted by comparing the
extracted ADRs with the original S PC. Subsequently, we obtai the numbers of true
positives (TP), false positives, and false negatives (FN). The ADR terms with only ‘c rrect’
label are considered as TP, both ‘near’ and ‘incorrect’ are FP, and the missing ADRs are
FN. The standard metrics of recall, precision, and F-score are calculated to measure the
performance of the proposed automated approach.
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3. Results
This section presents the results of our proposed ADR extraction method and the
manual evaluation results.
3.1. Overview
This study scrapes the SmPC documents of a total number of 647 marketed medicines,
from which 32,797 ADR terms and their frequencies are extracted. Among all extracted
ADR terms, 8069 are unique. The average number of ADR terms per medicine is 51. Table 2
offers a statistical overview of the extraction results from our selected medicines.
Table 2. Overview of the ADR extraction results.
Characteristics Statistics
# of selected marketed medicines 647
# of medicines with structured text 141
# of medicines with tabular text 419
# of medicines with free text 87
Average ADRs per medicine 51
25% percentile ADRs per medicine 21
50% percentile ADRs per medicine 38
75% percentile ADRs per medicine 67
Top medicines in terms of extracted
ADRs
1. Topamax 100 mg Tablets (269)
2. Revolade 25 mg film-coated tablets (255)
3. Capecitabine Accord 150 mg film coated tablets (240)
4. Glivec 100 mg film-coated tablets (232)
5. Risperdal 0.5 mg Film-Coated Tablets (218)
6. Xadago 50 mg film-coated tablets (215)
7. Invega 12 mg prolonged-release tablets (207)
8. LUSTRAL 100 mg film coated tablets (207)
9. Isentress 100 mg chewable tablets (191)
3.2. The Manual Evaluation Results
Clinical experts chose 37 commonly prescribed medicines for manual reviews. Ap-
pendix A provides a complete list of the 37 reviewed medicines. Among these chosen
medicines, there are 28 tabular texts, 7 structured texts, and 2 free texts. As explained
before, two experts participated in the manual evaluation. Table 3 shows the results of the
manual review, including some important performance scores, such as recall and precision.
For each medicine, the number of true positives, false positives, and false negatives are
counted. An extracted term is considered as true positive only when it is reviewed as a
correct ADR compared with the original text. False positives refer to the extracted terms
that are not ADRs. The missing ADRs are labeled as false negatives. The overall recall
and precision of all reviewed medicines are 0.99 and 0.932, respectively, which shows the
effectiveness of our ADR extraction approach and the reliability of its outputs.
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3.3. Error Analysis
Three main types of errors are identified among the 116 incorrect extracted ADRs of
Reviewer 1 (false positives). Table 4 summarizes the error analysis of incorrectly extracted
ADRs. Our approach encountered issues with splitting multiple ADR terms that are joined
by a colon or semicolon. For instance, two ADR terms (agitation and aggression) could
be extracted from ‘Agitation, aggression’. However, if multiple ADR terms are joined by
‘or’, ‘and’, or semicolon, such as the examples shown in Table 4, our extraction method
fails to properly address this. The second type of false-positive results is related to the data
cleaning of our approach. The extracted ADRs contain noises such as unrelated words or
special characters. As shown in the examples, to get the correct ADRs, we need to clean up
noises like ‘\u2020’, and ‘in combination with insulin or sulphonylurea’. Lastly, a small
number of extracted terms are not ADRs at all. For example, ‘skin and subcutaneous tissue
disorders’ is an SoC term that should be excluded from our final ADR lists. Since other
incorrect extractions do not belong to any specific group, it is difficult to exclude them.
However, the number of such errors is so small that its impact is limited.
Table 4. Error analysis for false positives.
Type of Error Examples Counts
Extracted Terms Correct ADRs




















Since there are only seven missing ADRs out of 1706 extracted ADRs, false-negative
(missing ADR) is not a common error. However, we found that such an error is more
likely to happen to medicines using free text to describe their ADRs. Since only 87 out
of the selected 647 medicines summarize their ADRs in free-text, and the number of
unstructured reported medicines has been steadily decreasing with recent SmPC updates,
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the false-negative error has a relatively limited and decreasing impact on the performance
of our approach.
4. Discussion
Many studies investigated the extraction of ADRs from SPLs from the FDA in the
USA, and some effective methods have been developed. However, as an equivalent in
Europe, the SmPC from the European Medicines Agency receives very little attention in the
field of NLP. In this study, we fill the research gap with the development of an automated
ADRs extraction method for the SmPC.
The manual experts review results demonstrate that our proposed method is effective
and has the potential of being used to solve ADR related clinical problems. Specifically, our
method achieves an overall recall of 0.990 and a precision of 0.932. Such high performance
has never been reported in previous studies focusing on extracting ADRs from SPLs [6,16].
As discussed in the error analysis, there are a few ways to further improve the
performance of our method. For example, noise in the extracted terms can be cleaned with
regular expressions. When it comes to the unsplit multiple ADRs, we can extend the split
function with more options so that it allows strings to be split by ‘or’, ‘and’, or semicolon.
Furthermore, encoding extracted ADR terms into MedDRA Preferred Terms could reduce
the non-ADR errors, thus further improving the performance.
Our study has some limitations. First, there are no standardized ADR annotations
based on the SmPC available to benchmark ADR extraction methods. It is difficult to
reproduce the performance of this study. Manual reviews from different experts might
present different performance scores.
Another limitation lies in the manual review process of this study. Involving clinical
experts in the manual review process is always challenging given their busy schedule. The
coronavirus has made the situation even worse. Therefore, the manual process in this
study only included one clinical expert. To compensate for this, we added one clinical NLP
expert as another reviewer. The NLP expert is familiar with this topic and was trained for
the task by the clinical expert. To address this, we plan to expand the manual review to a
larger size of samples and a bigger group of clinical experts in a post-COVID world.
The proposed ADR extraction method is developed based on data from the EMC in
UK. However, due to Brexit, product labels in UK might changes. Then the method will
not perform the same as shown in this study. Further development of this method should
focus on using the SmPCs from the EMA.
5. Conclusions
The contributions of this study are two-fold. First, it contributes to the field of clinical
NLP by introducing an open-source and reproducible method that extracts ADR terms
from the SmPC. The high-performance scores (recall: 0.99 and precision: 0.934) indicate our
approach is very effective, which leads us to believe that the method could be useful in the
processing and coding of ADRs in the SmPC. The second contribution lies in the clinical
field. The results of our extraction method are structured data that describes marketed
medicines and their recorded ADRs and frequencies. Such a knowledge base could be
applied to address practical clinical problems, ranging from ADR assessment in clinical
trials to assisting the detection of ADRs in patients.
Supplementary Materials: The following materials are available online at https://github.com/
ianshan0915/ade-extraction/paper, Appendix A: Appendix A-manual review results.xlsx. Source
code of the project is available on https://github.com/ianshan0915/ade-extraction.
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